NCT07197606View on ClinicalTrials.gov

Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in Subacute Ischemic Stroke

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Ischemic Stroke
Interventions
DRUG

Placebo

Intravenous injection of placebo

DRUG

IxCell hUC-MSC-S (Human Umbilical Cord Mesenchymal Stem Cells)

Intravenous injection of IxCell hUC-MSC-S

Trial Locations (1)

Unknown

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Shanghai IxCell Biotechnology Co., LTD

OTHER